STIM Earnings & Financial Statements
Neuronetics, Inc.
$1.89
-$0.10(-5.28%)
33
Overall
45
Value
9
Tech
47
Quality
Market Cap
$143.63M
Volume
818.18K
52W Range
$0.80 - $3.44
Target Price
$5.75
STIM earnings and financial statements: Neuronetics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
STIM Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $149.16M | $74.89M | $71.35M | $65.21M | $55.31M |
| Cost of revenue | $76.85M | $20.73M | $19.64M | $15.48M | $11.65M |
| Operating income | -$31.44M | -$34.56M | -$30.55M | -$35.11M | -$27.56M |
| EBITDA | -$26.43M | -$33.60M | -$22.14M | -$31.25M | -$26.81M |
| Net income | -$39.00M | -$43.71M | -$30.20M | -$37.16M | -$31.19M |
| EPS (diluted) | $-0.59 | $-1.38 | $-1.05 | $-1.38 | $-1.22 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $141.55M | $140.90M | $115.83M | $116.88M | $141.22M |
| Total liabilities | $115.31M | $109.10M | $81.64M | $59.82M | $56.05M |
| Shareholders’ equity | $22.38M | $27.71M | $34.19M | $57.06M | $85.17M |
| Cash and equivalents | $28.10M | $18.46M | $59.68M | $70.34M | $94.14M |
| Long-term debt | $84.74M | $77.84M | $61.63M | $25.80M | $38.87M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$20.37M | -$31.00M | -$32.00M | -$30.74M | -$27.98M |
| Capital expenditure | -$801.0K | -$1.47M | -$2.37M | -$3.27M | -$2.35M |
| Free cash flow | -$21.18M | -$32.46M | -$34.37M | -$34.01M | -$30.34M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STIM | $1.89 | -5.3% | 818.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |